Overview

This trial is active, not recruiting.

Condition bipolar disorder
Treatment far infrared
Phase phase 1
Sponsor GAAD Medical Research Institute Inc.
Start date September 2006
End date February 2008
Trial size 3 participants
Trial identifier NCT00573196, GAAD-BPC-CTP1

Summary

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model single group assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
far infrared
Far infrared radiation (5μm to 15μm wavelength)

Primary Outcomes

Measure
The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition.
time frame: 2 years

Secondary Outcomes

Measure
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia.
time frame: 2 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia Exclusion Criteria: - Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.

Additional Information

Official title Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Bipolar Condition
Principal investigator Kwasi Donyina, Ph.D.
Description A 2000 study in the American Journal of Psychiatry reported that, "in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells". This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant & entrepreneur Ted Turner, excelled in life due to the additional brain power! The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.
Trial information was received from ClinicalTrials.gov and was last updated in August 2009.
Information provided to ClinicalTrials.gov by GAAD Medical Research Institute Inc..